Back to blog
Selection 20 Sep 2026 · 19 min read

Why we added this company in Pharma + AI Data Centre sector on our watchlist

EMPIRICA INDIA | SELECTION · Watchlist addition · 18 September 2026

Why we added this company in Pharma + AI Data Centre sector on our watchlist

SHORT VERSION A maker of equipments for pharma factories, sales grew 43% in Q1FY27, has quietly become one of the fastest-growing engineering companies in India and has just announced it is entering the business of…

Continue reading with Empirica

This full article is available to Empirica subscribers. Unlock it — and all our research & portfolios — with a plan.

More from the blog

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026
Signal 12 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026

Two weeks ago, 13 of our portfolio companies had reported results for July to September 2026 (Q2 of the 2026–27 financial year, or Q2 FY27). Now 22 of 25 have reported, and 11 of them beat our expectations. In the last four trading days the Nifty Smallcap 250 rose about 3% and closed on Thursday above both its 10-day and 50-day averages. By our rules, that is a healthy market to put fresh money to work, and we have started: this week we added to two holdings.

Read more
Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26
Signal 01 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26

Results season for the July to September 2026 quarter (Q2 of the 2026–27 financial year, or Q2 FY27) is in full swing. 13 of our 23 portfolio companies have reported. 6 beat our expectations, 4 met them and 3 fell short. The other 10 report in the coming weeks. At the same time, the Nifty Smallcap 250 may be turning lower again after a short pause last week. A fall towards 16,000 is possible, so we are careful with fresh money.

Read more